Anti Diabetic effect of CL 316,243 (A β3-Adrenergic Agonist) by Down Regulation of Tumour Necrosis Factor (TNF-α) Expression

• Masoud Ghorbani ,

  * E-mail: mghorbani@irimc.org

  Affiliations Department of Microbiology and Immunology, Pasteur Institute of Iran, Tehran, Iran, Research and Production Complex, Pasteur Institute of Iran, Karaj, Iran, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada

  ⨯
• Mehdi Shafiee Ardestani,

  Affiliation Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran

  ⨯
• Sedigheh Hatami Gigloo,

  Affiliation Research and Production Complex, Pasteur Institute of Iran, Karaj, Iran

  ⨯
• Reza Ahangari Cohan,

  Affiliation Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran

  ⨯
• Davoud Nouri Inanlou,

  Affiliation Research and Production Complex, Pasteur Institute of Iran, Karaj, Iran

  ⨯
• Peyman Ghorbani

  Affiliation Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada

  ⨯